From Kitchen to Clinic
1 other identifier
interventional
120
1 country
1
Brief Summary
Children receiving cancer treatment often experience nutrition-related challenges, such as changes in appetite, weight, and food intake, due to treatment side effects and the demands placed on families during care. These challenges can increase caregiver stress, reduce diet quality, and contribute to short- and long-term health risks for children. While medically tailored meals have been shown to improve nutrition and reduce burden in adults with serious illness, their use in pediatric cancer care has not been well studied. This pilot study will evaluate the feasibility and acceptability of a 12-week, family-centered food-as-medicine program for children undergoing active cancer treatment and their caregivers. The program combines weekly delivery of medically tailored meals with individualized caregiver coaching provided by registered dietitian nutritionists. During the first eight weeks, families receive full meal support and weekly coaching sessions, followed by a four-week transition period with tapered meal delivery and bi-weekly coaching to support sustainable nutrition practices. A total of 60 pediatric patients and their caregivers will be enrolled at the Children's Hospital of Philadelphia. The study will assess whether families can be successfully recruited and retained, whether they are able to participate in study activities, and whether the program is acceptable and usable during cancer treatment. The study will also explore preliminary effects on children's dietary intake, weight and growth patterns, treatment tolerance, household nutrition security, and caregiver stress and burden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
March 9, 2026
December 1, 2025
2.5 years
January 21, 2026
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Recruitment feasibility
Participants enrolled per month of recruitment
Up to one year
Intervention Acceptability
Acceptability of the medically tailored meals and caregiver coaching program will be assessed using caregiver-focused questions developed by the investigators. Acceptability domains include overall program acceptability, acceptability of medically tailored meals, acceptability of caregiver coaching, and integration of the intervention into family routines. Responses are measured using a 5-point Likert scale, with higher scores indicating greater acceptability.
12 weeks (end of intervention)
Treatment adherence
Caregiver coaching adherence (dose received): Attendance rate Child and family meals consumed will be assessed using three complementary sources: 1. Weekly 3-item caregiver survey 2. Coaching call confirmation 3. Dietary recall cross-check The previous three sources will be used to calculate and confirm: % of provided child meals consumed ;% of family meals consumed A composite adherence score will be calculated: (0-100 index each week; averaged across weeks) Weekly Adherence Index = 0.50 × Child MTM uptake (%) * 0.20 × Family MTM uptake (%) * 0.30 × Coaching session completion (%)
Weeks 1 - 12 (intervention period)
Retention feasibility
Percent of participants providing assessment data at 12 weeks (end of treatment)
From enrollment until the end of treatment at 12 weeks
Assessment feasibility
Proportion of retained participants who provide valid data for each assessment task
From baseline to 12 months.
Secondary Outcomes (8)
Change in patient dietary intake
Baseline, 3, 6 and 12 months
Change in patient body mass index
Baseline, 3, 6 and 12 months
Household food security
Baseline, 3, 6 and 12 months
Household nutrition security
Baseline, 3, 6 and 12 months
Caregiver emotional distress - anxiety
Baseline, 3 months, 6 months, and 12 months
- +3 more secondary outcomes
Study Arms (1)
Medically tailored meals and caregiver coaching
EXPERIMENTALThis pilot study is a single-arm clinical trial. Sixty pediatric oncology patients and their caregivers (N=120) will be enrolled at the Children's Hospital of Philadelphia (Buerger and KOP locations).
Interventions
The total length of the intervention is 12 weeks. For 8 weeks, participants will receive weekly deliveries of 21 child-friendly MTMs plus snacks for the patient and 7 meals for the family, alongside weekly caregiver coaching sessions. In weeks 9-12, MTMs will taper to 1 meal/day for the patient, family meal support will continue, and coaching will shift to bi-weekly sessions.
For 8 weeks, participants will receive weekly deliveries of 21 child-friendly MTMs plus snacks for the patient and 7 meals for the family, alongside weekly caregiver coaching sessions. In weeks 9-12, MTMs will taper to 1 meal/day for the patient, family meal support will continue, and coaching will shift to bi-weekly sessions.
Eligibility Criteria
You may qualify if:
- Receiving cancer treatment for any cancer diagnosis
- Within the first 3-6 weeks of diagnosis i. Diagnosis date is defined as the date of the family meeting relaying diagnosis to the patient/caregiver/family
- At least 5-21 years of age at the time of enrollment
- English-speaking
- Approved to participate by both their oncologist and RDN
- Must anticipate to live in the same household as the designated caregiver for the duration of the study
You may not qualify if:
- Experiencing swallowing or digestive diseases/food allergies (e.g. celiacs, lactose intolerance, nut allergy), or specific food preferences that cannot be accommodated by MANNA.
- Receiving nutrition via nasogastric or gastric tube feedings
- Bone marrow transplant patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Drexel Universitylead
- Children's Hospital of Philadelphiacollaborator
Study Sites (1)
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2026
First Posted
March 6, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
March 9, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
IPD available upon reasonable request to PI